Critical Review: Magna-Lab (MAGAA) and BioLife Solutions (BLFS)

Magna-Lab (OTCMKTS:MAGAA) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, dividends and earnings.

Institutional & Insider Ownership

41.2% of BioLife Solutions shares are owned by institutional investors. 15.3% of Magna-Lab shares are owned by insiders. Comparatively, 38.5% of BioLife Solutions shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent recommendations for Magna-Lab and BioLife Solutions, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Magna-Lab 0 0 0 0 N/A
BioLife Solutions 0 0 4 0 3.00

BioLife Solutions has a consensus price target of $12.25, suggesting a potential downside of 2.08%.


This table compares Magna-Lab and BioLife Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Magna-Lab N/A N/A -2,947.37%
BioLife Solutions 10.42% 8.63% 7.84%

Volatility and Risk

Magna-Lab has a beta of 16.13, indicating that its share price is 1,513% more volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Valuation and Earnings

This table compares Magna-Lab and BioLife Solutions’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Magna-Lab N/A N/A -$140,000.00 N/A N/A
BioLife Solutions $11.02 million 21.00 -$2.51 million ($0.21) -59.57

Magna-Lab has higher earnings, but lower revenue than BioLife Solutions.


BioLife Solutions beats Magna-Lab on 7 of the 9 factors compared between the two stocks.

Magna-Lab Company Profile

Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. Magna-Lab Inc. was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.

BioLife Solutions Company Profile

BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 for cryopreservation of stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services; and contract aseptic manufacturing formulation, filling, and finishing services for liquid media products. It markets its products to the regenerative medicine, bio-banking, and drug discovery markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, and hair transplant centers, as well as suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. The company markets and sells its products directly using its sales force, as well as through; and through various regional distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.

Receive News & Ratings for Magna-Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magna-Lab and related companies with's FREE daily email newsletter.

Leave a Reply